AGILE THERAPEUTICS INC has a total of 115 patent applications. It increased the IP activity by 71.0%. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and surface technology and coating are MEHTA RAMAN, SYNCHRONEURON INC and MARINE INGREDIENTS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 25 | |
#2 | WIPO (World Intellectual Property Organization) | 13 | |
#3 | EPO (European Patent Office) | 12 | |
#4 | Canada | 11 | |
#5 | Australia | 8 | |
#6 | Hong Kong | 7 | |
#7 | China | 6 | |
#8 | Mexico | 6 | |
#9 | Brazil | 5 | |
#10 | Israel | 4 | |
#11 | New Zealand | 4 | |
#12 | Japan | 3 | |
#13 | Republic of Korea | 3 | |
#14 | South Africa | 3 | |
#15 | EAPO (Eurasian Patent Organization) | 2 | |
#16 | India | 1 | |
#17 | Norway | 1 | |
#18 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Surface technology and coating |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Layered products | |
#5 | Object sterilising | |
#6 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Kydonieus Agis | 76 |
#2 | Rossi Thomas M | 49 |
#3 | Foegh Marie | 24 |
#4 | Chien Te-Yen | 22 |
#5 | Arnold Charles G | 20 |
#6 | Conway Robert G | 17 |
#7 | Altomari Alfred F | 12 |
#8 | Rossi Thomas | 12 |
#9 | Agis Kydonieus | 9 |
#10 | Banga Ajay K | 7 |
Publication | Filing date | Title |
---|---|---|
US2020129524A1 | Personalized contraceptive formulations | |
WO2018009565A1 | Transdermal packaging membranes | |
CA2986039A1 | Contraceptive compositions and methods for improved efficacy and modulation of side effects | |
EP2773333A1 | Dermal delivery compositions and methods | |
WO2011088072A2 | Dermal delivery device | |
CA2756222A1 | Transdermal delivery | |
EP2343964A1 | Transdermal delivery | |
EP2343979A1 | Transdermal delivery | |
WO2010042607A1 | Transdermal delivery | |
US7384650B2 | Skin permeation enhancement composition for transdermal hormone delivery system | |
AU1788301A | Improved transdermal contraceptive delivery system and process | |
US7045145B1 | Transdermal contraceptive delivery system and process |